BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12627994)

  • 1. Fabry disease: recognition and management of cutaneous manifestations.
    Möhrenschlager M; Braun-Falco M; Ring J; Abeck D
    Am J Clin Dermatol; 2003; 4(3):189-96. PubMed ID: 12627994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatologic manifestations and neuropathic symptoms in women with Fabry disease.
    Melpignano A; Mandurino-Mirizzi A; Besagni F; Leri A
    Acta Biomed; 2014 May; 85(1):81-4. PubMed ID: 24897976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous complications of Anderson-Fabry disease.
    Giuseppe P; Daniele R; Rita BM
    Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V; Hein R; Ring J; Möhrenschlager M
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiokeratomas, not everything is Fabry disease.
    Cuestas D; Perafan A; Forero Y; Bonilla J; Velandia A; Gutierrez A; Motta A; Herrera H; Rolon M
    Int J Dermatol; 2019 Jun; 58(6):713-721. PubMed ID: 30656678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney function.
    Ries M; Schiffmann R
    Arch Dermatol; 2005 Jul; 141(7):904-5; author reply 905-6. PubMed ID: 16027312
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiokeratomas of Fabry successfully treated with intense pulsed light.
    Morais P; Santos AL; Baudrier T; Mota AV; Oliveira JP; Azevedo F
    J Cosmet Laser Ther; 2008 Dec; 10(4):218-22. PubMed ID: 18830871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
    Zampetti A; Orteu CH; Antuzzi D; Bongiorno MR; Manco S; Gnarra M; Morrone A; Cardinali G; Kovacs D; Aspite N; Linder D; Parini R; Feliciani C;
    Br J Dermatol; 2012 Apr; 166(4):712-20. PubMed ID: 22452439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fabry disease].
    Stephan F; Haber R
    Ann Dermatol Venereol; 2017 Feb; 144(2):137-146. PubMed ID: 28104284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathology and clinical manifestations of Fabry disease].
    Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
    Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiokeratoma corporis diffusum universale (Fabry disease)].
    Frank J; Jansen-Genzel W; Lentner A; Wienert V
    Hautarzt; 1996 Oct; 47(10):776-9. PubMed ID: 9036128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ; Astrin KH; Bishop DF
    Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease: an atypical presentation.
    Choudhury S; Meehan S; Shin HT
    Pediatr Dermatol; 2005; 22(4):334-7. PubMed ID: 16060871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
    Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
    Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiokeratoma corporis diffusum (Fabry disease). A lysosomal disease.
    Hashimoto K; Lieberman P; Lamkin N
    Arch Dermatol; 1976 Oct; 112(10):1416-23. PubMed ID: 183606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.